Brief: Star Combo Pharma Posts Q1 Fy23 Revenue Of A$6.55M
Nov 29 (Reuters) - Star Combo Pharma Ltd S66.AX :
* Q1 FY23 REVENUE OF A$6.55M
Source text for Eikon: ID:nASX1n0x6K
Further company coverage: S66.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Star Combo Pharma
See all newsBrief: Star Combo Pharma Announces Insurance Claim Settlement Of A$5 Million
Brief: Star Combo Pharma Says Outlook For FY2025 Is Positive
Brief: Star Combo Pharma Says HY Operating Loss Attributable A$4.4 Million
Brief: Star Combo Pharma Posts Q1 Fy23 Revenue Of A$6.55M
Australia's Star Combo Pharma plunges to record low on fire incident